Understanding how ureteric cancer is identified and diagnosed is crucial for anyone experiencing urinary symptoms or at risk for this rare condition. Knowing when to seek medical attention and what tests are involved can help reduce anxiety and ensure timely, appropriate care.

Introduction: Who Should Undergo Diagnostics

Ureteric cancer, also known as cancer of the ureter or upper tract urothelial carcinoma, is an uncommon disease that develops in the tubes connecting the kidneys to the bladder. Because it is rare, many people may not immediately recognize the warning signs or understand when they should seek medical evaluation.^[1]

You should consider seeking diagnostic evaluation if you notice blood in your urine, even if it appears only occasionally or in small amounts. This symptom, called hematuria (blood in the urine), is one of the most common early signs of ureteric cancer. Sometimes the blood is visible to the naked eye, making the urine appear pink, red, or dark. Other times, it can only be detected through laboratory testing.^[2][3]

Other symptoms that warrant medical attention include persistent pain in your back or side that doesn’t go away, especially pain located at the junction where your ribs meet your spine. Some people experience frequent urination, a strong urge to urinate, painful or burning sensations during urination, or unexplained weight loss and fatigue.^[3][9]

Certain groups of people should be particularly vigilant about these symptoms. Ureteric cancer occurs most often in older adults, typically those over the age of 60 or 65. People who have previously been treated for bladder cancer have an increased risk of developing ureteric cancer and should report any new or recurring urinary symptoms to their doctor promptly. Those with a personal history of smoking or exposure to certain industrial chemicals and dyes used in manufacturing leather goods, textiles, plastics, and rubbers should also be aware of their elevated risk.^[1][3][7]

Individuals with an inherited condition called Lynch Syndrome (a genetic disorder that increases cancer risk) also face a higher likelihood of developing upper tract urothelial carcinoma. Research suggests that approximately 21% of patients with this type of cancer carry a variant of Lynch Syndrome, making genetic factors an important consideration in some cases.^[2][7]

Classic Diagnostic Methods

When you visit your doctor with symptoms that might suggest ureteric cancer, the diagnostic process typically begins with a thorough discussion of your medical history and a physical examination. Your doctor will ask detailed questions about your symptoms, how long you’ve experienced them, and whether you have any risk factors such as smoking history, previous bladder cancer, or occupational exposures to chemicals.^[5]

During the physical exam, your healthcare provider will examine your abdomen and back, though it’s important to understand that a mass or enlarged kidney usually cannot be detected simply by touching the abdomen. This is why additional testing is necessary to properly evaluate the urinary tract and identify any abnormalities.^[3]

Urine Tests

One of the first diagnostic steps involves analyzing your urine. A urinalysis is a simple test that examines a sample of your urine for various abnormalities, including the presence of blood cells, infection markers, and other substances. This test can confirm whether blood is present in your urine, even when it’s not visible to the naked eye.^[5][6]

Your doctor may also order a urine cytology test, which looks for abnormal or cancerous cells that may have been shed from the lining of the urinary tract into the urine. A trained specialist examines the urine sample under a microscope to identify any concerning cells. While this test can provide valuable information, it’s important to note that it may not detect all cancers, particularly those that are low-grade or in very early stages.^[5][9]

Imaging Tests

Imaging tests create detailed pictures of the inside of your body and are essential for visualizing the ureters, kidneys, and surrounding structures. Several different imaging approaches may be used, depending on your specific situation and what your healthcare team needs to understand about your condition.^[5]

An intravenous pyelogram (IVP) is an X-ray examination of the urinary tract performed after injecting a special contrast dye into a vein. The dye travels through your bloodstream to your kidneys and urinary tract, making these structures visible on X-ray images. This test can reveal abnormalities in the shape or function of the ureters and kidneys.^[3][5]

A computerized tomography urogram (CT urogram) combines CT scanning technology with contrast dye to create highly detailed, three-dimensional images of the urinary tract. This test is particularly effective at showing the size, location, and extent of any tumors, as well as whether cancer may have spread beyond the ureter. The CT scanner moves around your body while you lie still on a table, taking multiple images from different angles that a computer then combines into cross-sectional views.^[5][6][9]

A magnetic resonance urogram (MR urogram) uses magnetic fields and radio waves instead of X-rays to create detailed images of the urinary tract. This test may be preferred for certain patients, such as those who cannot receive the contrast dye used in CT scans or who need additional information that MRI can provide.^[5][9]

Ultrasound examinations, particularly kidney ultrasound, use sound waves to create images of the kidneys and can help identify masses or other abnormalities. While ultrasound alone may not provide as much detail as CT or MRI for diagnosing ureteric cancer, it can be a useful initial screening tool or complement to other tests.^[3][6]

In some cases, a positron emission tomography scan (PET scan) may be ordered. This specialized imaging test uses a small amount of radioactive material to help identify areas where cancer cells are actively growing. PET scans are particularly useful for determining whether cancer has spread to other parts of the body.^[5]

Endoscopic Procedures

To directly visualize the inside of the urinary tract and obtain tissue samples for laboratory analysis, doctors use procedures involving thin, flexible tubes equipped with cameras and specialized tools. These procedures allow for both visual inspection and biopsy collection.^[5]

Ureteroscopy is a key diagnostic procedure for ureteric cancer. During this examination, your doctor inserts a thin, lighted tube called a ureteroscope through your urethra (the tube through which urine exits the body), passes it through your bladder, and advances it into your ureters. The camera on the end of the scope transmits images to a monitor, allowing your doctor to inspect the lining of the ureters and look for any suspicious areas or tumors.^[5][9]

If your doctor identifies an abnormal area during ureteroscopy, they can take a biopsy (a small tissue sample) for microscopic examination. The biopsy is then sent to a laboratory where a specialist called a pathologist examines the cells to determine whether cancer is present and, if so, what type and grade it is. This information is crucial for accurate diagnosis and treatment planning.^[5]

Sometimes a cystoscopy is also performed. This similar procedure examines the inside of the bladder using a cystoscope inserted through the urethra. Because ureteric cancer is closely related to bladder cancer and patients with ureteric cancer have an increased risk of bladder involvement, examining the bladder is an important part of the diagnostic workup.^[9]

Blood Tests and Additional Evaluations

Your doctor will likely order blood tests to assess your overall health and kidney function. These tests don’t diagnose ureteric cancer directly, but they provide important information about how well your kidneys are working and whether you’re healthy enough to undergo certain treatments. Blood tests may include measurements of kidney function markers, blood cell counts, and other indicators of general health.^[3][6]

Diagnostics for Clinical Trial Qualification

Clinical trials test new treatments or approaches to managing ureteric cancer. If you and your doctor are considering participation in a clinical trial, you’ll need to undergo specific diagnostic tests to determine whether you qualify for enrollment. These requirements help researchers ensure that study participants meet certain criteria and that the trial results will be meaningful and applicable.^[16]

The exact tests required vary depending on the specific clinical trial, but generally include comprehensive staging evaluations to determine the extent of your cancer. Staging involves determining whether the cancer is localized (confined to the ureter or renal pelvis), regional (spread to nearby lymph nodes or tissues), or metastatic (spread to distant parts of the body). This classification significantly influences which trials you might be eligible for, as many studies focus on specific stages of disease.^[3][8]

Complete imaging studies, including CT scans or MRI scans of the chest, abdomen, and pelvis, are typically required to thoroughly evaluate whether cancer has spread. These comprehensive imaging assessments create a complete picture of your disease and help determine the stage accurately.^[5]

Tissue samples obtained through biopsy are analyzed not only to confirm the diagnosis but also to determine the grade of the tumor. Grade refers to how abnormal the cancer cells look under a microscope and how quickly they’re likely to grow and spread. Low-grade tumors have cells that look relatively similar to normal cells and tend to grow slowly, while high-grade tumors have very abnormal-looking cells and tend to be more aggressive. Many clinical trials specify whether they’re enrolling patients with low-grade or high-grade disease.^[4][16]

Blood tests assessing kidney function are particularly important for clinical trial eligibility. Because many treatments for ureteric cancer can affect kidney function, and because some patients may have reduced kidney function due to the cancer itself or from having only one kidney, trials often have specific requirements about kidney function levels. Tests measuring how well your kidneys filter waste from your blood help determine whether you can safely receive certain experimental treatments.^[12]

Some clinical trials investigating targeted therapies require testing of your tumor tissue for specific genetic mutations or molecular markers. For example, trials testing drugs that target FGFR3 (fibroblast growth factor receptor 3) gene mutations require confirmation that your cancer carries this particular alteration. These specialized molecular tests examine the genetic makeup of cancer cells to identify specific changes that might respond to targeted drugs.^[7][16]

Documentation of any previous treatments is essential for trial enrollment. Your medical team will need complete records showing what treatments you’ve already received, how you responded to them, and how long ago they were administered. This information helps researchers understand whether experimental treatments might work for you and ensures that trial results accurately reflect the effectiveness of new approaches.^[12]

Some trials require baseline quality-of-life assessments or questionnaires about your symptoms and daily functioning. While these aren’t diagnostic tests in the traditional sense, they provide important information about how the disease and its treatment affect your life, which helps researchers measure whether new treatments provide meaningful benefits beyond just fighting cancer.